Skip to content

April sales dip at Rite Aid

Rite Aid Corp. reported a dip in same-store sales for April after seeing improved results in the previous month. The drug store chain said Thursday that same-store sales for the four weeks ended April 24 fell 1% from a year earlier. The company had posted flat same-store results in March after

CAMP HILL, Pa. — Rite Aid Corp. reported a dip in same-store sales for April after seeing improved results in the previous month.

The drug store chain said Thursday that same-store sales for the four weeks ended April 24 fell 1% from a year earlier. The company had posted flat same-store results in March after reporting declines of 3.2% in February, 2.1% in January and 1.8% in December.

In April, same-stores sales decreased 1.2% in the front end, compared with a 1.8% gain in March. Rite Aid noted that April and March front-end sales were impacted by an earlier Easter this year (April 4 versus April 12 last year).

For the combined March and April seasonal selling period, same-store sales in the front end increased by 0.3%.

Pharmacy same-store revenue was down 0.9% for April, a bit less than in the previous month. April same-store results in the pharmacy included a 103-basis-point negative impact from new generic drug introductions, and prescriptions filled at comparable stores fell 1.8% compared with a year earlier, according to Rite Aid.

Total drug store sales, meanwhile, declined 2% to $1.962 billion in April, compared with $2.003 billion a year ago.

For the eight-week year-to-date period ended April 24, same-store sales decreased 0.6%, reflecting a 0.3% gain in the front end and a 1% decrease in the pharmacy. Prescriptions filled at comparable stores dropped 1.6% over the prior-year period.

Total drug store sales for the year to date were down 1.7% to $3.93 billion from $4 billion in the year-ago span.

As of April 24, Rite Aid operated 4,773 stores, compared with 4,846 stores a year ago.

Comments

Latest

Ferrero reportedly will buy Kellogg for $3 billion

Ferrero reportedly will buy Kellogg for $3 billion

The Journal reported that WK Kellogg shareholders will receive $23 per share in cash—representing a premium of roughly 40% over recent trading levels. Including debt, the transaction gives WK Kellogg a total enterprise value of about $3.1 billion.

NCPA: PBM Reform Act must pass ASAP

NCPA: PBM Reform Act must pass ASAP

Systemic changes like those in the PBM Reform Act must pass and be enacted as soon as possible. We’re grateful for this bill’s introduction and will do everything we can to push it across the finish line.”